Vector Science and Therapeutics Corp. has seen a notable dip this week, amidst a backdrop of fluctuating trading volumes.
This week, shares of Vector Science and Therapeutics Corp. (PAIN.V) closed at C$1.83, marking a decrease of 6.63% over the past week. The stock has experienced significant volatility, reflected in its year-to-date performance, which shows a remarkable increase of 277.32%. However, the recent trend raises questions for investors as the stock faces headwinds.
Advertisement
Vector Science and Therapeutics Corp.
PAIN.V
PAIN.V
Vector Science and Therapeutics Corp.
WealthAwesomeMarket cap
$10.06M
52W high
$2.65
52W low
$0.35
1W change
-6.63%
Beta
4.67
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PAIN's historical volatility
30-Day Vol
101.6%
Annualized
90-Day Vol
102.0%
Annualized
Trend (90d)
-18.0%
Annualized drift
90d Mean
C$1.72
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.79 | C$1.26 – C$2.54 |
| 60 trading days | C$1.75 | C$1.07 – C$2.88 |
| 90 trading days | C$1.72 | C$0.93 – C$3.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While Vector Science and Therapeutics Corp. continues to show impressive year-to-date gains, the recent downward trend and low trading volume may warrant caution for investors considering entry points.
Key Performance Metrics for Vector Science and Therapeutics Corp.
With a market cap of C$10.07 million, Vector Science and Therapeutics Corp. has a profit margin of 0.0% and a return on equity of -104.1%, indicating challenges in profitability.
Bull case
The company has shown strong performance this year, suggesting potential for future growth as it navigates its market sector. The 200-day moving average indicates a positive long-term trend, which could appeal to long-term investors.
Bear case
The recent decline in stock price, along with significantly lower trading volume compared to its average, may signal waning investor interest. Additionally, the negative return on equity and profit margin could raise concerns for potential investors assessing the company’s financial health.
Recent Price Action
Advertisement
This week, Vector Science and Therapeutics Corp. (PAIN.V) has seen its stock price close at C$1.83, reflecting a 6.63% decrease over the past week. Despite the decline, the stock has shown a remarkable year-to-date increase of 277.32%, indicating strong performance earlier in the year.
Technical Picture
Analyzing the technical indicators, the current price of C$1.83 is slightly below the 50-day moving average of C$1.87, suggesting a minor short-term downtrend. The stock is trading above its 200-day moving average of C$1.71, which is a positive sign for long-term investors. The 52-week range of C$0.35 to C$2.65 shows that the stock is currently at 64% of its range, indicating potential for further movement within this bandwidth. With a beta of 4.67, the stock exhibits significant volatility compared to the overall market.
Volume Analysis
The latest trading volume for Vector Science and Therapeutics Corp. was reported at 18,884 shares, which is substantially lower than the 20-day average volume of 168,199 shares. This indicates a volume ratio of 0.47x, suggesting reduced trading activity and possible decreased investor interest in the stock.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
